AVAXIM

This brand name is authorized in Brazil, Canada, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Lithuania, Malta, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Tunisia, UK.

Active ingredients

The drug AVAXIM contains one active pharmaceutical ingredient (API):

1	Hepatitis A virus, purified inactivated UNII G54MT8V18G - HEPATITIS A VIRUS
	Inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, highly purified, formalin inactivated, and then adsorbed onto amorphous aluminum hydroxyphosphate sulphate.
	Read more about Hepatitis A, inactivated vaccine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AVAXIM Suspension for injection in a prefilled syringe	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07BC02	Hepatitis A, inactivated, whole virus	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BC Hepatitis vaccines
Discover more medicines within J07BC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	576720020055817, 576720020055917, 576720020056017
CA	Health Products and Food Branch	02237792
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	21.784-1-05-05, 25.633-04-04
EE	Ravimiamet	1024300
FI	Lääkealan turvallisuus- ja kehittämiskeskus	483443
FR	Base de données publique des médicaments	62756524, 63777215
GB	Medicines & Healthcare Products Regulatory Agency	30043, 30049
HK	Department of Health Drug Office	55399, 56399
LT	Valstybinė vaistų kontrolės tarnyba	1008337, 1035094, 1035095, 1035096
MT	Medicines Authority	AA1438/00201, AA1438/00202, AA770/17001
NG	Registered Drug Product Database	A6-0459
Switch country to Nigeria in order to find specific presentations of AVAXIM
NL	Z-Index G-Standaard	14090287
NL	Z-Index G-Standaard, PRK	62030
NZ	Medicines and Medical Devices Safety Authority	8769
PL	Rejestru Produktów Leczniczych	100195673
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W13439001, W13439002, W13439003, W13439004, W58081001, W58081002, W58081003, W58081004, W58081005, W58081006
SG	Health Sciences Authority	10611P, 13830P
TN	Direction de la Pharmacie et du Médicament	12063101
ZA	Health Products Regulatory Authority	30/30.1/0244, 35/30.1/0401